Legal & General Group’s Lunai Bioworks LNAI Stock Holding History

Legal & General Group’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-148	Closed	-$6.43K	–	3519
2025 Q1	$6.43K	Hold	148	–	–	﹤0.01%	3245
2024 Q4	$9.89K	Buy	148 +86	+139%	+$5.71K	﹤0.01%	3255
2024 Q3	$2.41K	Hold	62	–	–	﹤0.01%	3395
2024 Q2	$8.68K	Buy	+62	New	+$8.45K	﹤0.01%	3325
2023 Q2	–	Sell	-21	Closed	-$1.51K	–	3498
2023 Q1	$1.51K	Hold	21	–	–	﹤0.01%	3360
2022 Q4	$1.7K	Hold	21	–	–	﹤0.01%	3397
2022 Q3	$3K	Hold	21	–	–	﹤0.01%	3425
2022 Q2	$3K	Buy	+21	New	+$9.61K	﹤0.01%	3479
2021 Q2	–	Sell	-14	Closed	-$4K	–	3622
2021 Q1	$4K	Hold	14	–	–	﹤0.01%	3500
2020 Q4	$3K	Hold	14	–	–	﹤0.01%	3463
2020 Q3	$4K	Sell	14 -15	-52%	-$4.72K	﹤0.01%	3392
2020 Q2	$10K	Hold	29	–	–	﹤0.01%	3310
2020 Q1	$6K	Hold	29	–	–	﹤0.01%	3243
2019 Q4	$11K	Buy	+29	New	+$12.7K	﹤0.01%	3280

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Legal & General Group's LNAI Position: Q2 2025 in Review

Legal & General Group sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 148 shares — an estimated $6.43K sold.

Legal & General Group first reported a position in LNAI in Q4 2019 and held it in 14 quarters. The position peaked at $11K in Q4 2019. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

Legal & General Group reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
Legal & General Group sold 148 Lunai Bioworks shares in Q2 2025, an estimated $6.43K.
Legal & General Group first reported a position in Lunai Bioworks in Q4 2019 and held it in 14 quarters.
Legal & General Group's Lunai Bioworks position peaked at $11K in Q4 2019.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.